Gilead Wants Ex-Executive to Repay Millions for Insider Probe.

(Bloomberg) -- Gilead Sciences Inc. wants to claw back more than $4 million in legal fees the former chief financial officer of its Immunomedics unit racked up during a federal probe of insider trading allegations. Gilead's push to recoup Malik's fees is another in a growing wave of so-called clawback cases targeting both legal fees and compensation from executives involved in wrongdoing. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)